Dr. Julie Jackman, Pharm.D., BCPP | Amie Jo Digatono – Long-Acting Injectables: LAI Antipsychotics and Extended-Release Naltrexone – Pharmacists
Courses Content :
Salepage : Dr. Julie Jackman, Pharm.D., BCPP | Amie Jo Digatono – Long-Acting Injectables: LAI Antipsychotics and Extended-Release Naltrexone – Pharmacists
Archive : Dr. Julie Jackman, Pharm.D., BCPP | Amie Jo Digatono – Long-Acting Injectables: LAI Antipsychotics and Extended-Release Naltrexone – Pharmacists Digital Download
Delivery : Digital Download Immediately
A look at the FDA-approved indications for long-acting injectable (LAI) antipsychotics and extended-release naltrexone in the right patients. The mechanism of action, dose, the requirement for oral medication overlap, and potential side effects will all be investigated. Participants will evaluate and contrast the various long-acting injectable antipsychotics in order to determine which agent(s) may be most suited depending on patient and product factors. Participants will identify patients who may benefit from extended-release naltrexone and when it is suitable to start extended-release naltrexone. Finally, participants will be able to list the benefits and drawbacks of using long-acting injectable antipsychotics and extended-release naltrexone to uncover potential patient reasons for accepting these medicines.
List recent revisions to the Minnesota Pharmacy Act pertaining to pharmacist administration of drugs for alcohol/opioid use disorder and mental illness.
Examine the FDA-approved indications, modes of action, pharmacokinetics, side effects, and potential benefits of using long-acting injectable (LAI) antipsychotic drugs.
Examine the authorized indications, mechanism of action, pharmacokinetics, side effects, and use of extended-release naltrexone.
Compare LAI antipsychotics in terms of injection location, storage issues, administration preparation, requirement for loading doses, and amount to be administered.
After purchasing, you will receive a PDF including the training video and instructions for obtaining CE credits. To ensure CE recognition, the program must be completed within 30 days of purchase.
The Accreditation Council for Pharmacy Education (ACPE) has recognized the Minnesota Pharmacists Association as a continuing education provider. This knowledge-based program qualifies for a maximum of 1.5 contact hours for pharmacists and 1.5 contact hours for technicians who complete it successfully.
To get credit, participants must sign in, attend each session in its entirety, and complete a program assessment questionnaire.
To Receive CE Credit:
Statements of Credit will not be produced; instead, the MPhA will electronically submit your CE through the CPE Monitor System within 60 days of purchase. To upload the CE, you must supply MPhA with your NABP e-profile ID and birthday MMDD, as well as pass the final test with a minimum score of 70%. There is a Pharmacist Exam and a Technician Exam; please ensure that you purchase the appropriate course.
All CE will be accessible for one year beginning August 25, 2020.
Julie Jackman is a pharmacist who is Board Certified in Ambulatory Care and Psychiatric Pharmacy. She graduated from the University of Pittsburgh in 1999 and has been working in mental health since 2008. A patient’s capacity to care for themself might be hampered by mental illness. Dr. Jackman works hard to ensure that her patients do not fall between the gaps. In 2009, Pharmacy Today, a major pharmacy journal, acknowledged her unique practice. She was also named Minnesota’s Distinguished Young Pharmacist in 2009. In 2011, she was one of 512 pharmacists in the United States to get the Board Certified Ambulatory Care Pharmacist (BC-ACP) accreditation. She earned the American Pharmacist Association’s (APhA) Individual Immunization Champion Award in 2014 for her work in increasing immunization rates in the mental health community. In September 2014, she received the Excellence in Innovation Award from the Minnesota Pharmacists Association for her work with mental health patients using MTM. She will receive her BCPP in the fall of 2020. She is an active member of both the Minnesota Pharmacists Association (MPhA) and the American Pharmacist Association in order to fight for her patients (APhA).
Digatono, Amie Jo
2 Pharmacist – inpatient Mercy Hospital-Unity Campus Related Seminars and Products
Amie Jo Digatono, PharmD, BCPP, is an inpatient pharmacist at Mercy Hospital – Unity Campus in Fridley, MN, which treats medical and surgical patients as well as adult mental health and addiction treatments. She is dedicated about optimizing psychiatric drug usage via patient-centered treatment, interdisciplinary cooperation, and sharing her experience with students, residents, and others as a Board-Certified Psychiatric Pharmacist. Dr. Digatono also volunteers at the University of Minnesota College of Pharmacy, serves as a peer reviewer for the College of Psychiatric and Neurologic Pharmacists’ Mental Health Clinician, and is a Minneapolis election judge. She spends her free time with her husband and three loving felines tending to an overgrown native wildflower garden in Northeast Minneapolis.
More from Categories : Medical